Glibenclamide blunts coronary flow reserve induced by adenosine and dipyridamole

Scandinavian Cardiovascular Journal

Volumn 37, Issue 5, 2003, Pages 247-252

  Mortensen, Ulrik Markus ^a   Nielsen Kudsk, Jens Erik ^a   Jakobsen, Preben ^b   Toftegaard Nielsen, Torsten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Adenosine; Antidiabetic sulfonylureas; ATP sensitive potassium channels; Coronary flow reserve; Dipyridamole; Glibenclamide; Glyburide

Indexed keywords

ADENOSINE; ANTIDIABETIC AGENT; DIPYRIDAMOLE; GLIBENCLAMIDE; POTASSIUM CHANNEL; VASODILATOR AGENT;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DOPPLER FLOWMETRY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INTERACTION; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ADENOSINE; ANIMALS; CORONARY CIRCULATION; DRUG INTERACTIONS; GLYBURIDE; HYPOGLYCEMIC AGENTS; POTASSIUM CHANNELS; REGIONAL BLOOD FLOW; SWINE; VASODILATION; VASODILATOR AGENTS;

EID: 0142211248     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430310015217     Document Type: Article

References (25)

1. Aversano T, Ouyang P, Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 1991; 69(3): 618-622.
2. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Gunther K, Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990; 247(4948): 1341-1344.
3. Davis CA, Sherman AJ, Yaroshenko Y, et al. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea. J Am Coll Cardiol 1998; 31(4): 816-822.
4. Hein TW, Kuo L. cAMP-independent dilation of coronary arterioles to adenosine: Role of nitric oxide, G proteins, and K(ATP) channels. Circ Res 1999; 85(7): 634-642.
5. + channel activation. Am J Physiol 1993; 265(4 Pt 2): H1289-H1293.
6. Belloni FL, Hintze TH. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation. Am J Physiol 1991; 261(3 Pt 2): H720-H727.
7. Boyd AE, Aguilar-Bryan L, Nelson DA. Molecular mechanisms of action of glyburide on the beta cell. Am J Med 1990; 89(2A): 3S-10S.
8. + channels in arterial smooth muscle. Science 1989; 245(4914): 177-180.
9. + channel blocker. Circulation 1994; 90(2): 700-705.
10. Cleveland JCJ, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 96(1): 29-32.
11. + channel opening: A new drug principle in cardiovascular medicine. Heart 1996; 76(2): 109-116.
12. Mellemkjaer S, Nielsen-Kudsk JE. Effects of levcromakalim and glibenclamide on paced guinea-pig atrial strips exposed to hypoxia. Eur J Pharmacol 1995; 277(1): 51-56.
13. 99mTc-sestamibi in the presence of total coronary artery occlusion. Am Heart J 1990; 119(4): 842-847.
14. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39(4): 578-582.
15. + ATP channels in coronary vasodilation during exercise. Circulation 1993; 88(3): 1245-1253.
16. + ATP channels in local metabolic coronary vasodilation. Am J Physiol 1999; 277(6 Pt 2): H2115-H2123.
17. Samaha FF, Heineman FW, Ince C, Fleming J, Balaban RS. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol 1992; 262(5 Pt 1): C1220-C1227.
18. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol 1992; 263(2 Pt 2): H399-H404.
19. Sartor G, Melander A, Schersten B, Wahlin-Boll E. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 1980; 18(1): 17-22.
20. Sundell J, Nuutila P, Laine H, et al. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes 2002; 51(4): 1125-1130.
21. Farouque HM, Worthley SG, Meredith IT, Skyrme-Jones RA, Zhang MJ. Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. Circ Res 2002; 90(2): 231-236.
22. Reffelmann T, Klues HG, Hanrath P, Schwarz ER. Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease. Heart 2002; 87(1): 54-60.
23. Bottcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 1995; 36(11): 2016-2021.
24. Nagamachi S, Czernin J, Kim AS, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996; 37(10): 1626-1631.
25. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DRJ. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999; 33(1): 119-124.